Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28M Buy
1,724,803
+251,295
+17% +$4.48M ﹤0.01% 2332
2026
Q1
$28.1M Buy
1,473,508
+32,271
+2% +$624K ﹤0.01% 2238
2025
Q4
$23.6M Buy
1,441,237
+730,905
+103% +$12.9M ﹤0.01% 2425
2025
Q3
$13.3M Buy
710,332
+251,825
+55% +$4.52M ﹤0.01% 2986
2025
Q2
$9.26M Buy
458,507
+141,422
+45% +$2.44M ﹤0.01% 3155
2025
Q1
$4.36M Sell
317,085
-394,187
-55% -$5.43M ﹤0.01% 3926
2024
Q4
$8.43M Buy
711,272
+479,884
+207% +$7.55M ﹤0.01% 3250
2024
Q3
$4.15M Buy
231,388
+168,691
+269% +$3.08M ﹤0.01% 3265
2024
Q2
$1.1M Sell
62,697
-173,914
-74% -$3.59M ﹤0.01% 4333
2024
Q1
$6.07M Buy
236,611
+159,805
+208% +$4.01M ﹤0.01% 2771
2023
Q4
$2M Sell
76,806
-132,638
-63% -$3.03M ﹤0.01% 3825
2023
Q3
$4.83M Buy
209,444
+89,844
+75% +$2.25M ﹤0.01% 2603
2023
Q2
$2.81M Sell
119,600
-30,959
-21% -$525K ﹤0.01% 3192
2023
Q1
$1.79M Sell
150,559
-7,508
-5% -$107K ﹤0.01% 3549
2022
Q4
$2.42M Buy
158,067
+48,292
+44% +$845K ﹤0.01% 3204
2022
Q3
$2.09M Buy
109,775
+1,601
+1% +$31.8K ﹤0.01% 3121
2022
Q2
$1.94M Buy
108,174
+4,762
+5% +$110K ﹤0.01% 3175
2022
Q1
$3.11M Sell
103,412
-5,443
-5% -$170K ﹤0.01% 3026
2021
Q4
$3.13M Sell
108,855
-507
-0.5% -$16.5K ﹤0.01% 3315
2021
Q3
$4.39M Buy
109,362
+102,483
+1,490% +$4.58M ﹤0.01% 2803
2021
Q2
$300K Sell
6,879
-191,488
-97% -$7.92M ﹤0.01% 5089
2021
Q1
$7.47M Buy
198,367
+34,911
+21% +$1.49M ﹤0.01% 2214
2020
Q4
$6.48M Buy
163,456
+38,850
+31% +$1.59M ﹤0.01% 2204
2020
Q3
$5.2M Buy
124,606
+10,155
+9% +$464K ﹤0.01% 2168
2020
Q2
$4.81M Buy
114,451
+112,115
+4,799% +$3.44M ﹤0.01% 2077
2020
Q1
$45K Buy
2,336
+1,348
+136% +$45.6K ﹤0.01% 5917
2019
Q4
$38K Buy
+988
New +$37.1K ﹤0.01% 6518

Other funds holding XP

UBS Group's XP Position: Q2 2026 in Review

UBS Group increased its XP (XP) stake by 17% in Q2 2026, buying an estimated $4.48M and bringing the position to 1,724,803 shares worth $28M. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

UBS Group first reported a position in XP in Q4 2019 and has held it in 27 quarters since. The position peaked at $28.1M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • UBS Group held 1,724,803 shares of XP worth $28M as of Q2 2026.
  • UBS Group bought 251,295 XP shares in Q2 2026, an estimated $4.48M.
  • XP made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2332 holding.
  • UBS Group first reported a position in XP in Q4 2019 and has held it in 27 quarters since.
  • UBS Group's XP position peaked at $28.1M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.